In conclusion, the transcription factor PROX1, with a widespread role in CNS development, is a prognostic marker for IDH-mutant high-grade astrocytomas that evolve through multi-step genetic alterations over time. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).